Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BMY · as of Jun 8, 2026
Key Statistics
Explore Bristol-Myers Squibb Company Data
bmy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 41 · Buy rate: 46.3%
The BMY analyst consensus is Hold, based on ratings from 41 Wall Street analysts over the past 3 months. The average 12-month price target is $61.73, representing +7.79% upside from the current price of $57.27.
Competitors & Peers
bmy competitorsBMY
CI
CVS
ELV
GSK
HCAStock Performance
Full HistoryAbout Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fib…
what is bristol-myers squibb company · bmy stock overview · bristol-myers squibb company company profile · who is bristol-myers squibb company ceo · bmy NYSE · bristol-myers squibb company headquarters · bristol-myers squibb company business segments
About Stock Overview & Key Data
Bristol-Myers Squibb Company (BMY) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Jun 1, 1972. As of the latest trading session, BMY stock price is $57.27, with a market capitalization of $116.9B. The stock has returned +16.88% over the past 12 months and +6.17% year-to-date.
According to 41 Wall Street analysts, the consensus rating for Bristol-Myers Squibb Company stock is Hold, with an average 12-month price target of $61.73. In fiscal year 2025, Bristol-Myers Squibb Company reported revenue of $48.2B and net income of $7.1B. For detailed data — including Bristol-Myers Squibb Company revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bristol-Myers Squibb Company (BMY) stock price is $57.27. The stock is traded on NYSE under the ticker symbol BMY. The 52-week range is $42.52 – $62.89.